Growth hormone regulates the balance between bone formation and bone marrow adiposity

Philip J. Menagh, Russell T. Turner, Donald B. Jump, Carmen P. Wong, Malcolm B. Lowry, Shoshana Yakar, Clifford J. Rosen, Urszula T. Iwaniec

Research output: Contribution to journalArticle

Abstract

Cancellous bone decreases and bone marrow fat content increases with age. Osteoblasts and adipocytes are derived from a common precursor, and growth hormone (GH), a key hormone in integration of energy metabolism, regulates the differentiation and function of both cell lineages. Since an age-related decline in GH is associated with bone loss, we investigated the relationship between GH and bone marrow adiposity in hypophysectomized (HYPOX) rats and in mice with defects in GH signaling. HYPOX dramatically reduced body weight gain, bone growth and mineralizing perimeter, serum insulin-like growth factor 1 (IGF-1) levels, and mRNA levels for IGF-1 in liver and bone. Despite reduced body mass and adipocyte precursor pool size, HYPOX resulted in a dramatic increase in bone lipid levels, as reflected by increased bone marrow adiposity and bone triglyceride and cholesterol content. GH replacement normalized bone marrow adiposity and precursor pool size, as well as mineralizing perimeter in HYPOX rats. In contrast, 17β-estradiol, IGF-1, thyroxine, and cortisone were ineffective. Parathyroid hormone (PTH) reversed the inhibitory effects of HYPOX on mineralizing perimeter but had no effect on adiposity. Finally, bone marrow adiposity was increased in mice deficient in GH and IGF-1 but not in mice deficient in serum IGF-1. Taken together, our findings indicate that the reciprocal changes in bone and fat mass in GH signaling-deficient rodents are not directly coupled with one another. Rather, GH enhances adipocyte as well as osteoblast precursor pool size. However, GH increases osteoblast differentiation while suppressing bone marrow lipid accumulation.

Original languageEnglish (US)
Pages (from-to)757-768
Number of pages12
JournalJournal of Bone and Mineral Research
Volume25
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Adiposity
Osteogenesis
Growth Hormone
Bone Marrow
Bone and Bones
Somatomedins
Osteoblasts
Adipocytes
Fats
Lipids
Bone Development
Cortisone
Cell Lineage
Parathyroid Hormone
Serum
Thyroxine
Energy Metabolism
Weight Gain
Estradiol
Rodentia

Keywords

  • Adipocytes
  • Estrogen
  • IGF-1
  • Osteoblasts
  • Parathyroid hormone

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Menagh, P. J., Turner, R. T., Jump, D. B., Wong, C. P., Lowry, M. B., Yakar, S., ... Iwaniec, U. T. (2010). Growth hormone regulates the balance between bone formation and bone marrow adiposity. Journal of Bone and Mineral Research, 25(4), 757-768. https://doi.org/10.1359/jbmr.091015

Growth hormone regulates the balance between bone formation and bone marrow adiposity. / Menagh, Philip J.; Turner, Russell T.; Jump, Donald B.; Wong, Carmen P.; Lowry, Malcolm B.; Yakar, Shoshana; Rosen, Clifford J.; Iwaniec, Urszula T.

In: Journal of Bone and Mineral Research, Vol. 25, No. 4, 04.2010, p. 757-768.

Research output: Contribution to journalArticle

Menagh, PJ, Turner, RT, Jump, DB, Wong, CP, Lowry, MB, Yakar, S, Rosen, CJ & Iwaniec, UT 2010, 'Growth hormone regulates the balance between bone formation and bone marrow adiposity', Journal of Bone and Mineral Research, vol. 25, no. 4, pp. 757-768. https://doi.org/10.1359/jbmr.091015
Menagh, Philip J. ; Turner, Russell T. ; Jump, Donald B. ; Wong, Carmen P. ; Lowry, Malcolm B. ; Yakar, Shoshana ; Rosen, Clifford J. ; Iwaniec, Urszula T. / Growth hormone regulates the balance between bone formation and bone marrow adiposity. In: Journal of Bone and Mineral Research. 2010 ; Vol. 25, No. 4. pp. 757-768.
@article{1f75c718bcd0410e9540be848d66886f,
title = "Growth hormone regulates the balance between bone formation and bone marrow adiposity",
abstract = "Cancellous bone decreases and bone marrow fat content increases with age. Osteoblasts and adipocytes are derived from a common precursor, and growth hormone (GH), a key hormone in integration of energy metabolism, regulates the differentiation and function of both cell lineages. Since an age-related decline in GH is associated with bone loss, we investigated the relationship between GH and bone marrow adiposity in hypophysectomized (HYPOX) rats and in mice with defects in GH signaling. HYPOX dramatically reduced body weight gain, bone growth and mineralizing perimeter, serum insulin-like growth factor 1 (IGF-1) levels, and mRNA levels for IGF-1 in liver and bone. Despite reduced body mass and adipocyte precursor pool size, HYPOX resulted in a dramatic increase in bone lipid levels, as reflected by increased bone marrow adiposity and bone triglyceride and cholesterol content. GH replacement normalized bone marrow adiposity and precursor pool size, as well as mineralizing perimeter in HYPOX rats. In contrast, 17β-estradiol, IGF-1, thyroxine, and cortisone were ineffective. Parathyroid hormone (PTH) reversed the inhibitory effects of HYPOX on mineralizing perimeter but had no effect on adiposity. Finally, bone marrow adiposity was increased in mice deficient in GH and IGF-1 but not in mice deficient in serum IGF-1. Taken together, our findings indicate that the reciprocal changes in bone and fat mass in GH signaling-deficient rodents are not directly coupled with one another. Rather, GH enhances adipocyte as well as osteoblast precursor pool size. However, GH increases osteoblast differentiation while suppressing bone marrow lipid accumulation.",
keywords = "Adipocytes, Estrogen, IGF-1, Osteoblasts, Parathyroid hormone",
author = "Menagh, {Philip J.} and Turner, {Russell T.} and Jump, {Donald B.} and Wong, {Carmen P.} and Lowry, {Malcolm B.} and Shoshana Yakar and Rosen, {Clifford J.} and Iwaniec, {Urszula T.}",
year = "2010",
month = "4",
doi = "10.1359/jbmr.091015",
language = "English (US)",
volume = "25",
pages = "757--768",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Growth hormone regulates the balance between bone formation and bone marrow adiposity

AU - Menagh, Philip J.

AU - Turner, Russell T.

AU - Jump, Donald B.

AU - Wong, Carmen P.

AU - Lowry, Malcolm B.

AU - Yakar, Shoshana

AU - Rosen, Clifford J.

AU - Iwaniec, Urszula T.

PY - 2010/4

Y1 - 2010/4

N2 - Cancellous bone decreases and bone marrow fat content increases with age. Osteoblasts and adipocytes are derived from a common precursor, and growth hormone (GH), a key hormone in integration of energy metabolism, regulates the differentiation and function of both cell lineages. Since an age-related decline in GH is associated with bone loss, we investigated the relationship between GH and bone marrow adiposity in hypophysectomized (HYPOX) rats and in mice with defects in GH signaling. HYPOX dramatically reduced body weight gain, bone growth and mineralizing perimeter, serum insulin-like growth factor 1 (IGF-1) levels, and mRNA levels for IGF-1 in liver and bone. Despite reduced body mass and adipocyte precursor pool size, HYPOX resulted in a dramatic increase in bone lipid levels, as reflected by increased bone marrow adiposity and bone triglyceride and cholesterol content. GH replacement normalized bone marrow adiposity and precursor pool size, as well as mineralizing perimeter in HYPOX rats. In contrast, 17β-estradiol, IGF-1, thyroxine, and cortisone were ineffective. Parathyroid hormone (PTH) reversed the inhibitory effects of HYPOX on mineralizing perimeter but had no effect on adiposity. Finally, bone marrow adiposity was increased in mice deficient in GH and IGF-1 but not in mice deficient in serum IGF-1. Taken together, our findings indicate that the reciprocal changes in bone and fat mass in GH signaling-deficient rodents are not directly coupled with one another. Rather, GH enhances adipocyte as well as osteoblast precursor pool size. However, GH increases osteoblast differentiation while suppressing bone marrow lipid accumulation.

AB - Cancellous bone decreases and bone marrow fat content increases with age. Osteoblasts and adipocytes are derived from a common precursor, and growth hormone (GH), a key hormone in integration of energy metabolism, regulates the differentiation and function of both cell lineages. Since an age-related decline in GH is associated with bone loss, we investigated the relationship between GH and bone marrow adiposity in hypophysectomized (HYPOX) rats and in mice with defects in GH signaling. HYPOX dramatically reduced body weight gain, bone growth and mineralizing perimeter, serum insulin-like growth factor 1 (IGF-1) levels, and mRNA levels for IGF-1 in liver and bone. Despite reduced body mass and adipocyte precursor pool size, HYPOX resulted in a dramatic increase in bone lipid levels, as reflected by increased bone marrow adiposity and bone triglyceride and cholesterol content. GH replacement normalized bone marrow adiposity and precursor pool size, as well as mineralizing perimeter in HYPOX rats. In contrast, 17β-estradiol, IGF-1, thyroxine, and cortisone were ineffective. Parathyroid hormone (PTH) reversed the inhibitory effects of HYPOX on mineralizing perimeter but had no effect on adiposity. Finally, bone marrow adiposity was increased in mice deficient in GH and IGF-1 but not in mice deficient in serum IGF-1. Taken together, our findings indicate that the reciprocal changes in bone and fat mass in GH signaling-deficient rodents are not directly coupled with one another. Rather, GH enhances adipocyte as well as osteoblast precursor pool size. However, GH increases osteoblast differentiation while suppressing bone marrow lipid accumulation.

KW - Adipocytes

KW - Estrogen

KW - IGF-1

KW - Osteoblasts

KW - Parathyroid hormone

UR - http://www.scopus.com/inward/record.url?scp=77953469123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953469123&partnerID=8YFLogxK

U2 - 10.1359/jbmr.091015

DO - 10.1359/jbmr.091015

M3 - Article

VL - 25

SP - 757

EP - 768

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 4

ER -